Drugs and Clinical Trials Rules, 2019
On 26th March, 2019, the Government notified the new Drugs and Clinical Trials Rules, 2019, reducing the time for approving applications to 30 days for drugs manufactured in India and 90 days for those developed outside the country.
Nodal Ministry: Ministry of Health & Family Welfare
Aim
- The aim is to promote clinical research in India, have predictable, transparent and effective regulations for such trials and to make faster accessibility of new drugs to the Indian population.
Reason for Such Move
- According to the Central Drugs Standard Control Organisation (CDSCO), the number of patients with rare diseases is quite low, making ....
Do You Want to Read More?
Subscribe Now
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Related Content
- 1 India Philanthropy Report 2025
- 2 “Imagine a World with More Women in Science’’ Campaign
- 3 Swavalambini: Empowering Women Entrepreneurs
- 4 BIMSTEC Youth Summit 2025
- 5 NHRC’s Core Group Meeting on ASHAs
- 6 Concerns of PwDs over DPDP Rules
- 7 Nari Adalats: Women-only Courts for Alternative Dispute Resolution
- 8 NITI Aayog’s Workshop on Enabling Women-Led Development through Entrepreneurship
- 9 India Hosts First-Ever Regional Dialogue on Social Justice
- 10 Revised Guidelines on Obesity Diagnosis & Treatment
